Before you read
Subject: A vaccine producer in Northeast China’s Jilin province is under investigation for law violations in producing rabies vaccines for human use, China’s…
Excerpt: English text from the archived bilingual edition · Chinese edition
Reference text and retained source material
A vaccine producer in Northeast China’s Jilin province is under investigation for law violations in producing rabies vaccines for human use, China’s top drug regulator announced on Sunday
Changchun Changsheng Bio-tech Co, in Changchun, was found to have serious irregularities, including fabricating production records in the manufacture of rabies vaccines for human use, during an inspection by the State Drug Administration, the administration said in a statement
The administration conducted an unannounced inspection of the company after being tipped off regarding suspected irregularities, it said. The statement did not mention when the inspection took place
No products involved in the inspection were on sale, and all the vaccines involved have been removed, it said
The State administration ordered Jilin Provincial Drug Administration to suspend production of rabies vaccines, it said. The provincial administration has sent an investigation team to the company, it said
The State Drug Administration will continue to put its priority on drug safety and impose the strictest supervision to ensure public safety in the use of drugs, it said
Legal and contractual language: using this material
Read definitions, parties and obligations in the complete clause rather than transplanting isolated terms between legal systems. Check cross-references, annexes and revisions. Translation is not legal advice.
